HYAL-2–WWOX–SMAD4 Signaling in Cell Death and Anticancer Response

Li‐Jin Hsu, Ming‐Fu Chiang, Chun‐I Sze, Wan‐Pei Su, Ye Vone Yap, Ivan Lee, Hsiang‐Ling Kuo, Nan‐Shan ChangFrontiers in Cell and Developmental Biology 2016 · DOI

Abstract

Hyaluronidase HYAL-2 is a membrane-anchored protein and also localizes, in part, in the lysosome. Recent study from animal models revealed that both HYAL-1 and HYAL-2 are essential for the metabolism of hyaluronan (HA). Hyal-2 deficiency is associated with chronic thrombotic microangiopathy with hemolytic anemia in mice due to over accumulation of high molecular size HA. HYAL-2 is essential for platelet generation. Membrane HYAL-2 degrades HA bound by co-receptor CD44. Also, in a non-canonical signal pathway, HYAL-2 serves as a receptor for transforming growth factor beta (TGF-β) to signal with downstream tumor suppressors WWOX and SMAD4 to control gene transcription. When SMAD4 responsive element is overly driven by the HYAL-2-WWOX-SMAD4 signaling complex, cell death occurs. When rats are subjected to traumatic brain injury, over accumulation of a HYAL-2-WWOX complex occurs in the nucleus to cause neuronal death. HA induces the signaling of HYAL-2-WWOX-SMAD4 and relocation of the signaling complex to the nucleus. If the signaling complex is overexpressed, bubbling cell death occurs in WWOX-expressing cells. In addition, a small synthetic peptide Zfra (zinc finger-like protein that regulates apoptosis) binds membrane HYAL-2 of non-T/non-B spleen HYAL-2+ CD3- CD19- Z lymphocytes and activates the cells to generate memory anticancer response against many types of cancer cells in vivo. Whether the HYAL-2-WWOX-SMAD4 signaling complex is involved is discussed. In this review and opinion article, we have updated the current knowledge of HA, HYAL-2 and WWOX, HYAL-2-WWOX-SMAD4 signaling, bubbling cell death, and Z cell activation for memory anticancer response.

Introduction

The metabolism of hyaluronan (HA), a primary component of the extracellular matrix, is a well-established biological process. However, the signaling roles of the enzymes involved, particularly hyaluronidase HYAL-2, have remained largely enigmatic. Traditionally viewed as a simple metabolic enzyme, HYAL-2 is now recognized as a critical receptor in a non-canonical signaling pathway. This pathway involves the tumor suppressor WWOX and the transcription factor SMAD4, forming a triad that regulates a unique form of cell death and orchestrates a potent anticancer immune response. Understanding this pathway is vital, as WWOX dysfunction is implicated in 30–50% of human cancers and various neurodegenerative conditions.

The Signaling Triad and Bubbling Cell Death

HYAL-2 functions as a cognate receptor for Transforming Growth Factor beta 1 (TGF-β1). Upon activation, HYAL-2 recruits WWOX and SMAD4 to form a signaling complex. This triad then translocates from the cytoplasm to the nucleus to modulate gene expression. A remarkable consequence of over-activating this pathway is the induction of "bubbling cell death."

The HYAL-2–WWOX–SMAD4 signaling complex and its role in triggering 'bubbling' cell death.

Unlike traditional apoptosis, bubbling cell death is caspase-independent. It is characterized by the formation of a single, large, nitric oxide-containing bubble that originates from the nucleus. As the bubble expands, it eventually causes the cell membrane to rupture, or "pop." This mechanism is distinct from "blebbing," which can occur without resulting in cell death, particularly when other factors like p53 are involved. Interestingly, the same HYAL-2–WWOX nuclear accumulation observed in cancer cell death has been linked to neuronal loss following traumatic brain injury (TBI), suggesting a shared pathological pathway across different disease states.

Z Cells and the Zfra Peptide: A Novel Anticancer Strategy

A significant breakthrough in this research is the identification of "Z cells"—a novel population of non-T/non-B spleen lymphocytes defined by the markers HYAL-2+ CD3- CD19-. These cells can be specifically activated by a 31-amino-acid synthetic peptide called Zfra (zinc finger-like protein that regulates apoptosis).

In vivo activation of Z cells by Zfra peptide and subsequent cancer resistance.

The Zfra peptide binds to membrane-anchored HYAL-2 on Z cells, "educating" them to recognize and eliminate various types of cancer cells. Research using truncated versions of the peptide, such as Zfra4-10, has identified the minimal functional units necessary for this anticancer activity. This peptide-driven activation bypasses the need for traditional adjuvants and induces a robust, memory-like immune response.

Key Results and Clinical Implications

Experimental models have demonstrated the potent efficacy of this pathway:

  • Potent Cytotoxicity: Overexpression of the HYAL-2–WWOX–SMAD4 complex can lead to over 95% cell death in targeted populations.
  • Tumor Inhibition: In vivo studies showed that the Zfra4-10 peptide blocked the growth of skin basal cell carcinoma (BCC) by 50–75%.
  • Adoptive Transfer: Transferring Zfra-activated Z cells into naive recipient mice conferred immediate resistance to cancer growth, highlighting the potential for novel cell-based immunotherapies.
  • WWOX Structural Switch: The research proposes a structural "switch" for WWOX, where phosphorylation at Tyr33 transitions the protein from a "closed" inactive state to an "open" active state, essential for its tumor-suppressive role.

Limitations and Future Directions

While the discovery of the HYAL-2–WWOX–SMAD4 triad and Z cell activation is promising, several questions remain. The precise mechanism by which extracellular Zfra polymers trigger internal WWOX phosphorylation is not yet fully understood. Furthermore, while the "open/closed" model for WWOX is supported by functional data, high-resolution structural biology studies of the full triad complex are needed for confirmation.

The most critical next step is clinical translation. While the Z cell response is well-documented in murine models, identifying and characterizing the human equivalent of these cells is essential to determine if Zfra-based therapies can be successfully adapted for human cancer treatment.

Summary updated

Abstract

Hyaluronidase HYAL-2 is a membrane-anchored protein and also localizes, in part, in the lysosome. Recent study from animal models revealed that both HYAL-1 and HYAL-2 are essential for the metabolism of hyaluronan (HA). <i>Hyal-2</i> deficiency is associated with chronic thrombotic microangiopathy with hemolytic anemia in mice due to over accumulation of high molecular size HA. HYAL-2 is essential for platelet generation. Membrane HYAL-2 degrades HA bound by co-receptor CD44. Also, in a non-canonical signal pathway, HYAL-2 serves as a receptor for transforming growth factor beta (TGF-β) to signal with downstream tumor suppressors WWOX and SMAD4 to control gene transcription. When SMAD4 responsive element is overly driven by the HYAL-2-WWOX-SMAD4 signaling complex, cell death occurs. When rats are subjected to traumatic brain injury, over accumulation of a HYAL-2-WWOX complex occurs in the nucleus to cause neuronal death. HA induces the signaling of HYAL-2-WWOX-SMAD4 and relocation of the signaling complex to the nucleus. If the signaling complex is overexpressed, bubbling cell death occurs in WWOX-expressing cells. In addition, a small synthetic peptide Zfra (zinc finger-like protein that regulates apoptosis) binds membrane HYAL-2 of non-T/non-B spleen HYAL-2<sup>+</sup> CD3<sup>-</sup> CD19<sup>-</sup> Z lymphocytes and activates the cells to generate memory anticancer response against many types of cancer cells <i>in vivo</i>. Whether the HYAL-2-WWOX-SMAD4 signaling complex is involved is discussed. In this review and opinion article, we have updated the current knowledge of HA, HYAL-2 and WWOX, HYAL-2-WWOX-SMAD4 signaling, bubbling cell death, and Z cell activation for memory anticancer response.
BibTeX
@inproceedings{hsu2016hyal,
  author = {Li‐Jin Hsu and Ming‐Fu Chiang and Chun‐I Sze and Wan‐Pei Su and Ye Vone Yap and Ivan Lee and Hsiang‐Ling Kuo and Nan‐Shan Chang},
  title = {{HYAL-2–WWOX–SMAD4 Signaling in Cell Death and Anticancer Response}},
  booktitle = {Frontiers in Cell and Developmental Biology},
  year = {2016},
  doi = {10.3389/fcell.2016.00141},
}
Figure